newsfilter
← Latest News
GlobeNewswire·

Kinnate Biopharma Inc. Announces FDA Clearance of Investigational Drug Application for KIN-3248

SAN FRANCISCO and SAN DIEGO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (NASDAQ:KNTE) ("Kinnate"), a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomicall